Chimeric antigen receptor T cell therapy and nephrotoxicity: From diagnosis to treatment strategies.
作者： Hua Zhou , Min Yang , Li Cui , Jingting Jiang
DOI: 10.1016/J.INTIMP.2020.107072
关键词:
摘要: Chimeric antigen receptor T (CAR-T) cell therapy is a breakthrough in cancer treatment. With the widespread use of this therapy, increasing evidence available that CAR-T associated with acute kidney injury (AKI). Nephrologists need to understand potential nephrotoxicity arising from therapy. Determining cause AKI key factor clinical management. This review focuses on and outcomes its use. We also provide suggestions for clinicians towards both better diagnosis management those receiving
sci-hub.st 参考文章(80)
Michael Joannidis, Wilfred Druml, Lui G. Forni, A. B. Johan Groeneveld, Patrick Honore, Heleen M. Oudemans-van Straaten, Claudio Ronco, Marie R. C. Schetz, Arend Jan Woittiez, Prevention of acute kidney injury and protection of renal function in the intensive care unit Intensive Care Medicine. ,vol. 36, pp. 392- 411 ,(2010) , 10.1007/S00134-009-1678-Y
Shivani Srivastava, Stanley R. Riddell, Engineering CAR-T Cells: Design Concepts Trends in Immunology. ,vol. 36, pp. 494- 502 ,(2015) , 10.1016/J.IT.2015.06.004
James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler-Stevenson, Steven A. Feldman, Irina Maric, Mark Raffeld, Debbie-Ann N. Nathan, Brock J. Lanier, Richard A. Morgan, Steven A. Rosenberg, Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19 Blood. ,vol. 116, pp. 4099- 4102 ,(2010) , 10.1182/BLOOD-2010-04-281931
Renier Brentjens, Raymond Yeh, Yvette Bernal, Isabelle Riviere, Michel Sadelain, Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial Molecular Therapy. ,vol. 18, pp. 666- 668 ,(2010) , 10.1038/MT.2010.31
Shannon L. Maude, David Barrett, David T. Teachey, Stephan A. Grupp, Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies The Cancer Journal. ,vol. 20, pp. 119- 122 ,(2014) , 10.1097/PPO.0000000000000035
Mark D. Okusa, Andrew Davenport, Reading between the (guide)lines—the KDIGO practice guideline on acute kidney injury in the individual patient Kidney International. ,vol. 85, pp. 39- 48 ,(2014) , 10.1038/KI.2013.378
James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose, William G. Telford, Frances T. Hakim, David C. Halverson, Daniel H. Fowler, Nancy M. Hardy, Anthony R. Mato, Dennis D. Hickstein, Juan C. Gea-Banacloche, Steven Z. Pavletic, Claude Sportes, Irina Maric, Steven A. Feldman, Brenna G. Hansen, Jennifer S. Wilder, Bazetta Blacklock-Schuver, Bipulendu Jena, Michael R. Bishop, Ronald E. Gress, Steven A. Rosenberg, Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. ,vol. 122, pp. 4129- 4139 ,(2013) , 10.1182/BLOOD-2013-08-519413
Lakhmir S. Chawla, Paul W. Eggers, Robert A. Star, Paul L. Kimmel, Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes The New England Journal of Medicine. ,vol. 371, pp. 58- 66 ,(2014) , 10.1056/NEJMRA1214243
Daniel W. Lee, Rebecca Gardner, David L. Porter, Chrystal U. Louis, Nabil Ahmed, Michael Jensen, Stephan A. Grupp, Crystal L. Mackall, Current concepts in the diagnosis and management of cytokine release syndrome. Blood. ,vol. 124, pp. 188- 195 ,(2014) , 10.1182/BLOOD-2014-05-552729
Leonard H. Calabrese, Stefan Rose-John, IL-6 biology: implications for clinical targeting in rheumatic disease Nature Reviews Rheumatology. ,vol. 10, pp. 720- 727 ,(2014) , 10.1038/NRRHEUM.2014.127